\-\ Texto\\:\\ \ \(0\)\
\-\ she\\ is\\ now\\ 15\\.8\\ kg\\.\\ \\ vital\\ signs\\ at\\ last\\ exam\\ were\\ hr\\ 120\\,\\ bp\\ 93\\/68\\,\\ and\\ rr\\ 24\\.\\ \\ no\\ sao2\\ is\\ reported\\.\\ \\ she\\ has\\ no\\ central\\ cyanosis\\,\\ clubbing\\,\\ or\\ peripheral\\ edema\\.\\ \\ she\\ is\\ in\\ no\\ respiratory\\ distress\\.\\ \\ her\\ heart\\ has\\ a\\ regular\\ rate\\ and\\ rhythm\\,\\ normal\\ s1\\ and\\ s2\\,\\ and\\ no\\ audible\\ murmurs\\.\\ \\ ekg\\ is\\ unchanged\\ with\\ sinus\\ rhythm\\,\\ l\\ axis\\ deviation\\,\\ and\\ nonspecific\\ t\\-wave\\ abnormality\\.\ \(0\)\
\-\ cxr\\ and\\ other\\ subsequent\\ studies\\ were\\ obtained\\ leading\\ to\\ a\\ diagnosis\\.\ \(0\)\
\-\ the\\ patient\\ is\\ now\\ growing\\ well\\ without\\ any\\ new\\ complaints\\ and\\ is\\ being\\ followed\\ by\\ cardiology\\ and\\ hematology\\/oncology\\ every\\ 3\\-6\\ months\\.\\ \\ she\\ has\\ remained\\ asymtopmatic\\ without\\ murmurs\\ and\\ evidence\\ of\\ cardiovascular\\ failure\\ despite\\ this\\ large\\ mass\\.\ \(0\)\
\-\ options\\ to\\ remove\\ the\\ tumor\\ are\\ unlikely\\ \\ because\\ of\\ its\\ size\\ and\\ lv\\ wall\\ involvement\\,\\ arguably\\ infiltrating\\ the\\ intraventricular\\ septum\\.\\ \\ further\\ considerations\\ for\\ chemotherapy\\ are\\ being\\ discussed\\ if\\ she\\ becomes\\ symptomatic\\.\\ \\ as\\ a\\ last\\ option\\ a\\ heart\\ transplant\\ is\\ also\\ being\\ considered\\.\ \(0\)\
\-\ cxr\\ \\-\\ patient\\ is\\ slightly\\ rotated\\ to\\ right\\.\\ \\ enlarged\\ heart\\ size\\ with\\ irregular\\ borders\\.\\ \\ lungs\\ clear\\ except\\ small\\ lung\\ volume\\ l\\<r\\ 2nd\\ to\\ the\\ heart\\ size\\.\ \(0\)\
\-\ ct\\ w\\/iv\\ contrast\\ \\-\\ intracardiac\\ mass\\ of\\ the\\ left\\ ventricle\\.\\ \\ no\\ pleural\\ effusion\\ or\\ pericardial\\ infiltration\\.\\ \\ \\(mild\\ disagreement\\ between\\ echo\\ and\\ ct\\ regarding\\ interseptal\\ involvement\\ of\\ the\\ mass\\ with\\ echo\\ showing\\ mild\\ superior\\ interseptal\\ involvement\\ and\\ ct\\ showing\\ none\\.\\)\ \(0\)\
\-\ reconstructed\\ ct\\ image\\ w\\/contrast\\ \\-\\ very\\ little\\ perfusion\\ to\\ a\\ large\\ area\\ of\\ the\\ left\\ ventricular\\ wall\\ c\\/w\\ large\\ mass\\.\ \(0\)\
\-\ radionuclear\\ perfusion\\ study\\ \\-\\ no\\ evidence\\ of\\ perfusion\\ to\\ the\\ lateral\\ wall\\ of\\ the\\ left\\ ventricle\\.\\ \\ accurate\\ ejection\\ fraction\\ unable\\ to\\ be\\ obtained\\.\ \(0\)\
\-\ intracardiac\\ fibroma\ \(0\)\
\-\ given\\ the\\ relatively\\ benign\\ clinical\\ course\\ thus\\ far\\ with\\ a\\ nonperfusing\\,\\ very\\ slowly\\ growing\\ intracardiac\\ mass\\,\\ a\\ benign\\ tumor\\ is\\ likely\\:\ \(0\)\
\-\ rhabdomyoma\\ \\-\\ the\\ most\\ common\\ intracardiac\\ tumor\\ of\\ childhood\\,\\ usually\\ small\\ and\\ most\\ commonly\\ in\\ the\\ left\\ ventricle\\.\ \(0\)\
\-\ fibroma\\ \\-\\ next\\ most\\ common\\ \\(though\\ very\\ uncommon\\)intracardiac\\ tumor\\ of\\ childhood\\,\\ usually\\ involves\\ intraventricular\\ septum\\ but\\ is\\ also\\ found\\ in\\ left\\ ventricular\\ free\\ wall\\.\\ \ \(0\)\
\-\ myxoma\\ \\-\\ rare\\ in\\ childhood\\ and\\ usually\\ involves\\ either\\ atria\\.\ \(0\)\
\-\ 22\\ month\\ old\\ girl\\ born\\ at\\ term\\ via\\ an\\ uncomplicated\\ delivery\\.\\ \\ her\\ postnatal\\ course\\ is\\ complicated\\ only\\ by\\ tachypnea\\.\ \(0\)\
\-\ nearly\\ all\\ benign\\ cardiac\\ tumors\\ found\\ at\\ birth\\ or\\ during\\ early\\ childhood\\ are\\ either\\ a\\ rhabdomyoma\\ or\\ fibroma\\.\\ \\ rhabdomyomas\\ are\\ by\\ far\\ the\\ most\\ common\\ benign\\ cardiac\\ tumor\\,\\ most\\ occuring\\ before\\ the\\ age\\ of\\ 1\\ yr\\.\\ \\ they\\ most\\ often\\ occur\\ in\\ within\\ ventricular\\ walls\\ \\(left\\ \\-80\\%\\,\\ right\\ \\-15\\%\\)\\ but\\ can\\ occur\\ on\\ the\\ atrioventricular\\ valves\\.\\ \\ 80\\-90\\%\\ of\\ rhabdomyomas\\ are\\ associated\\ with\\ tuberous\\ sclerosis\\.\\ \\ typically\\,\\ they\\ regress\\ spontaneously\\ and\\ require\\ only\\ outpatient\\ follow\\-up\\ with\\ cardiology\\.\\ \\ rarely\\ they\\ proliferate\\ and\\ cause\\ obstruction\\ and\\ heart\\ failure\\.\\ \\ treatment\\ for\\ symptomatic\\ children\\ includes\\ surgical\\ resection\\,\\ chemo\\,\\ or\\ rarely\\ a\\ heart\\ transplant\\.\\ \\ fibromas\\ are\\ less\\ common\\ and\\ typically\\ have\\ a\\ less\\ benign\\ course\\.\\ \\ they\\ typically\\ involve\\ the\\ intraventricular\\ septum\\ or\\ the\\ left\\ ventricular\\ free\\ wall\\.\\ \\ there\\ has\\ been\\ reported\\ atrial\\ involvement\\ as\\ well\\ as\\ tumor\\ growth\\ impeding\\ either\\ the\\ mitral\\ or\\ aortic\\ valves\\ leading\\ to\\ stenosis\\ and\\/or\\ regurgitation\\.\\ \\ fibromas\\,\\ unlike\\ rhabdomyomas\\,\\ do\\ not\\ regress\\ spontaneously\\ but\\ typically\\ continue\\ to\\ grow\\.\\ \\ this\\ can\\ impede\\ blood\\ flow\\,\\ cause\\ conduction\\ disturbances\\,\\ and\\ hinder\\ chamber\\ filling\\ and\\ overall\\ cardiac\\ function\\ leading\\ to\\ heart\\ failure\\.\\ \\ patients\\ can\\ be\\ followed\\ clinically\\ until\\ they\\ become\\ symptomatic\\.\\ \\ they\\ will\\ likely\\ need\\ resection\\ of\\ the\\ tumor\\,\\ chemotherapy\\,\\ or\\ cardiac\\ transplant\\.\ \(0\)\
\-\ this\\ patient\\ is\\ currently\\ asymptomatic\\.\\ \\ her\\ tumor\\ is\\ growing\\;\\ however\\,\\ she\\ continues\\ to\\ show\\ no\\ signs\\ of\\ cardiac\\ impairment\\.\\ \\ as\\ mentioned\\ above\\,\\ recent\\ studies\\ were\\ inconclusive\\ regarding\\ the\\ cardiac\\ output\\ and\\ efficiency\\.\\ \\ however\\,\\ her\\ tumor\\ is\\ growing\\ and\\ now\\ occupies\\ a\\ larger\\ volume\\ of\\ her\\ left\\ ventricle\\.\\ \\ her\\ tumor\\ 3\\ days\\ after\\ birth\\ measured\\ 1\\.8\\ x\\ 2\\.8\\ x\\ 3\\.0\\ cm\\ with\\ a\\ lv\\ size\\ \\(including\\ tumor\\)\\ approximately\\ 3\\.1\\ x\\ 4\\.0\\ x\\ 3\\.9\\ cm\\.\\ \\ eighteen\\ months\\ later\\ her\\ tumor\\ measured\\ 4\\.5\\ x\\ 5\\.9\\ x\\ 4\\.2\\ cm\\ \\ with\\ a\\ lv\\ size\\ \\(including\\ tumor\\)\\ of\\ 6\\.1\\ x\\ 5\\.8\\ x\\ 4\\.2\\ cm\\.\\ \\ her\\ tumor\\ volume\\ was\\ about\\ 31\\%\\ of\\ the\\ lv\\ size\\ at\\ birth\\ compared\\ to\\ 75\\%\\ eighteen\\ months\\ later\\ showing\\ it\\ is\\ becoming\\ more\\ of\\ a\\ space\\ occupying\\ lesion\\ and\\ likely\\ will\\ soon\\ become\\ symptomatic\\.\\ \\ given\\ the\\ size\\ of\\ her\\ tumor\\ treatment\\ options\\ are\\ limited\\ to\\ a\\ chemotherapy\\ trial\\ \\ or\\ a\\ heart\\ transplant\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ intracardiac\\:\\ 0\\.04406373246385473\ \(0\)\
\-\ tumor\\:\\ 0\\.03749496176180949\ \(0\)\
\-\ rhabdomyomas\\:\\ 0\\.033182628948430985\ \(0\)\
\-\ lv\\:\\ 0\\.030328379933383772\ \(0\)\
\-\ heart\\:\\ 0\\.029802556074366614\ \(0\)\
\-\ her\\:\\ 0\\.02901468623132299\ \(0\)\
\-\ x\\:\\ 0\\.02829677626446652\ \(0\)\
\-\ size\\:\\ 0\\.025162021455020576\ \(0\)\
\-\ cardiac\\:\\ 0\\.024503162807661006\ \(0\)\
\-\ childhood\\:\\ 0\\.024131419014976296\ \(0\)\
\-\ growing\\:\\ 0\\.023694724525693336\ \(0\)\
\-\ transplant\\:\\ 0\\.023694724525693336\ \(0\)\
\-\ they\\:\\ 0\\.02317901726339252\ \(0\)\
\-\ interseptal\\:\\ 0\\.02212175263228732\ \(0\)\
\-\ rhabdomyoma\\:\\ 0\\.02038236196588846\ \(0\)\
\-\ eighteen\\:\\ 0\\.019364883651940747\ \(0\)\
\-\ ventricular\\:\\ 0\\.019163393476548975\ \(0\)\
\-\ intraventricular\\:\\ 0\\.018690228941994128\ \(0\)\
\-\ benign\\:\\ 0\\.01850094333145045\ \(0\)\
\-\ perfusion\\:\\ 0\\.018309691488275045\ \(0\)\
\-\ she\\:\\ 0\\.018058615870420368\ \(0\)\
\-\ fibroma\\:\\ 0\\.017898652748130787\ \(0\)\
\-\ symptomatic\\:\\ 0\\.017038812670987263\ \(0\)\
\-\ fibromas\\:\\ 0\\.016903580633090744\ \(0\)\
\-\ septum\\:\\ 0\\.01645997679100194\ \(0\)\
\-\ \\-\\:\\ 0\\.01608795384060043\ \(0\)\
\-\ ventricle\\:\\ 0\\.016072222421974543\ \(0\)\
\-\ involvement\\:\\ 0\\.015718638176300207\ \(0\)\
\-\ regress\\:\\ 0\\.015685242324981082\ \(0\)\
\-\ wall\\:\\ 0\\.015527974405512837\ \(0\)\
\-\ birth\\:\\ 0\\.015455413636088449\ \(0\)\
\-\ leading\\:\\ 0\\.015388195502838736\ \(0\)\
\-\ volume\\:\\ 0\\.015193456452402642\ \(0\)\
\-\ typically\\:\\ 0\\.01513889972148543\ \(0\)\
\-\ most\\:\\ 0\\.01485195840698677\ \(0\)\
\-\ showing\\:\\ 0\\.014803198875960329\ \(0\)\
\-\ 4\\.2\\:\\ 0\\.014732947163864637\ \(0\)\
\-\ either\\:\\ 0\\.014009165206372909\ \(0\)\
\-\ cardiology\\:\\ 0\\.013945851658582222\ \(0\)\
\-\ valves\\:\\ 0\\.013424799300293026\ \(0\)\
\-\ failure\\:\\ 0\\.012600219383305019\ \(0\)\
\-\ regarding\\:\\ 0\\.012569274615297813\ \(0\)\
\-\ \\%\\:\\ 0\\.012505150773814352\ \(0\)\
\-\ course\\:\\ 0\\.012137508570096517\ \(0\)\
\-\ far\\:\\ 0\\.012111755024848741\ \(0\)\
\-\ spontaneously\\:\\ 0\\.012111755024848741\ \(0\)\
\-\ very\\:\\ 0\\.011675479115898854\ \(0\)\
\-\ measured\\:\\ 0\\.011646502268684718\ \(0\)\
\-\ murmurs\\:\\ 0\\.011533276584166603\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.01152928149990288\ \(0\)\
\-\ cm\\:\\ 0\\.011502916526057644\ \(0\)\
\-\ or\\:\\ 0\\.011309541707243876\ \(0\)\
\-\ common\\:\\ 0\\.011223423899404752\ \(0\)\
\-\ being\\:\\ 0\\.011208737679299467\ \(0\)\
\-\ echo\\:\\ 0\\.011157015235883253\ \(0\)\
\-\ rhythm\\:\\ 0\\.011125449910395524\ \(0\)\
\-\ 93\\/68\\:\\ 0\\.01106087631614366\ \(0\)\
\-\ asymtopmatic\\:\\ 0\\.01106087631614366\ \(0\)\
\-\ arguably\\:\\ 0\\.01106087631614366\ \(0\)\
\-\ disagreement\\:\\ 0\\.01106087631614366\ \(0\)\
\-\ radionuclear\\:\\ 0\\.01106087631614366\ \(0\)\
\-\ nonperfusing\\:\\ 0\\.01106087631614366\ \(0\)\
\-\ \\-15\\:\\ 0\\.01106087631614366\ \(0\)\
\-\ impeding\\:\\ 0\\.01106087631614366\ \(0\)\
\-\ hinder\\:\\ 0\\.01106087631614366\ \(0\)\
\-\ now\\:\\ 0\\.010995416272402688\ \(0\)\
\-\ is\\:\\ 0\\.01058263698340136\ \(0\)\
\-\ options\\:\\ 0\\.010419270589346125\ \(0\)\
\-\ rarely\\:\\ 0\\.010281103017995992\ \(0\)\
\-\ are\\:\\ 0\\.010231012682192236\ \(0\)\
\-\ become\\:\\ 0\\.010214771130748427\ \(0\)\
\-\ w\\/iv\\:\\ 0\\.01019118098294423\ \(0\)\
\-\ impede\\:\\ 0\\.01019118098294423\ \(0\)\
\-\ involves\\:\\ 0\\.009965699717711184\ \(0\)\
\-\ l\\:\\ 0\\.00977550187738613\ \(0\)\
\-\ usually\\:\\ 0\\.009767609487578767\ \(0\)\
\-\ 15\\.8\\:\\ 0\\.009682441825970374\ \(0\)\
\-\ t\\-wave\\:\\ 0\\.009682441825970374\ \(0\)\
\-\ atrioventricular\\:\\ 0\\.009682441825970374\ \(0\)\
\-\ proliferate\\:\\ 0\\.009682441825970374\ \(0\)\
\-\ efficiency\\:\\ 0\\.009682441825970374\ \(0\)\
\-\ left\\:\\ 0\\.009597041598724362\ \(0\)\
\-\ \\-80\\:\\ 0\\.009321485649744802\ \(0\)\
\-\ \\,\\:\\ 0\\.009170855419029811\ \(0\)\
\-\ last\\:\\ 0\\.009161185570998705\ \(0\)\
\-\ likely\\:\\ 0\\.009072609658478004\ \(0\)\
\-\ cxr\\:\\ 0\\.009049014482120645\ \(0\)\
\-\ free\\:\\ 0\\.008826100520498021\ \(0\)\
\-\ months\\:\\ 0\\.008785224446763114\ \(0\)\
\-\ 24\\.\\:\\ 0\\.008619332841795715\ \(0\)\
\-\ hematology\\/oncology\\:\\ 0\\.008619332841795715\ \(0\)\
\-\ 5\\.8\\:\\ 0\\.008619332841795715\ \(0\)\
\-\ occupies\\:\\ 0\\.008451790316545372\ \(0\)\
\-\ 5\\.9\\:\\ 0\\.008451790316545372\ \(0\)\
\-\ w\\/contrast\\:\\ 0\\.008304007335797087\ \(0\)\
\-\ 80\\-90\\:\\ 0\\.00817181095479605\ \(0\)\
\-\ 6\\.1\\:\\ 0\\.00817181095479605\ \(0\)\
\-\ has\\:\\ 0\\.008053701232091733\ \(0\)\
\-\ postnatal\\:\\ 0\\.008052224781892254\ \(0\)\
\-\ occur\\:\\ 0\\.008045286395938616\ \(0\)\
\-\ studies\\:\\ 0\\.008008785239094504\ \(0\)\
\-\ a\\:\\ 0\\.007961852985066022\ \(0\)\
\-\ chemo\\:\\ 0\\.007943051159571515\ \(0\)\
\-\ inconclusive\\:\\ 0\\.007943051159571515\ \(0\)\
\-\ 4\\.0\\:\\ 0\\.007943051159571515\ \(0\)\
\-\ atria\\:\\ 0\\.007842621162490541\ \(0\)\
\-\ occuring\\:\\ 0\\.007842621162490541\ \(0\)\
\-\ chamber\\:\\ 0\\.007842621162490541\ \(0\)\
\-\ reported\\:\\ 0\\.007817000879738549\ \(0\)\
\-\ sao2\\:\\ 0\\.007749637508596285\ \(0\)\
\-\ reconstructed\\:\\ 0\\.007749637508596285\ \(0\)\
\-\ including\\:\\ 0\\.0077425812822909\ \(0\)\
\-\ later\\:\\ 0\\.0077425812822909\ \(0\)\
\-\ 3\\.9\\:\\ 0\\.0076630717978221925\ \(0\)\
\-\ obtained\\:\\ 0\\.007623252448541635\ \(0\)\
\-\ myxoma\\:\\ 0\\.007582094983345943\ \(0\)\
\-\ no\\:\\ 0\\.007557225915842677\ \(0\)\
\-\ signs\\:\\ 0\\.007546740110379057\ \(0\)\
\-\ becoming\\:\\ 0\\.0075060289584821605\ \(0\)\
\-\ mass\\:\\ 0\\.0074558406960324\ \(0\)\
\-\ audible\\:\\ 0\\.0074343120025976575\ \(0\)\
\-\ 3\\-6\\:\\ 0\\.0074343120025976575\ \(0\)\
\-\ c\\/w\\:\\ 0\\.0074343120025976575\ \(0\)\
\-\ 120\\:\\ 0\\.007366473581932318\ \(0\)\
\-\ given\\:\\ 0\\.007351102616101235\ \(0\)\
\-\ were\\:\\ 0\\.007303461744127683\ \(0\)\
\-\ fraction\\:\\ 0\\.00730211562159662\ \(0\)\
\-\ output\\:\\ 0\\.00730211562159662\ \(0\)\
\-\ 2\\.8\\:\\ 0\\.00730211562159662\ \(0\)\
\-\ can\\:\\ 0\\.007295692669268768\ \(0\)\
\-\ less\\:\\ 0\\.007262082821386906\ \(0\)\
\-\ cause\\:\\ 0\\.00725536418206265\ \(0\)\
\-\ 3\\.1\\:\\ 0\\.007240898351622427\ \(0\)\
\-\ 4\\.5\\:\\ 0\\.007240898351622427\ \(0\)\
\-\ followed\\:\\ 0\\.007189148987148735\ \(0\)\
\-\ large\\:\\ 0\\.007033409404633926\ \(0\)\
\-\ yr\\:\\ 0\\.007022136259847298\ \(0\)\
\-\ disturbances\\:\\ 0\\.007022136259847298\ \(0\)\
\-\ accurate\\:\\ 0\\.006972925829291111\ \(0\)\
\-\ ejection\\:\\ 0\\.006972925829291111\ \(0\)\
\-\ grow\\:\\ 0\\.006972925829291111\ \(0\)\
\-\ to\\:\\ 0\\.0069659791841390475\ \(0\)\
\-\ kg\\:\\ 0\\.006925572845623801\ \(0\)\
\-\ rotated\\:\\ 0\\.006925572845623801\ \(0\)\
\-\ conduction\\:\\ 0\\.006879942175396855\ \(0\)\
\-\ 1\\.8\\:\\ 0\\.006879942175396855\ \(0\)\
\-\ but\\:\\ 0\\.0068601128018828264\ \(0\)\
\-\ found\\:\\ 0\\.006757906184321486\ \(0\)\
\-\ unchanged\\:\\ 0\\.006752234905246363\ \(0\)\
\-\ unlike\\:\\ 0\\.006752234905246363\ \(0\)\
\-\ trial\\:\\ 0\\.006752234905246363\ \(0\)\
\-\ soon\\:\\ 0\\.006712399650146513\ \(0\)\
\-\ will\\:\\ 0\\.006708860773849791\ \(0\)\
\-\ resection\\:\\ 0\\.00668736676416617\ \(0\)\
\-\ occupying\\:\\ 0\\.006673790291718967\ \(0\)\
\-\ clubbing\\:\\ 0\\.0066363336252827304\ \(0\)\
\-\ 3\\.0\\:\\ 0\\.0066363336252827304\ \(0\)\
\-\ regurgitation\\:\\ 0\\.006599962813647533\ \(0\)\
\-\ mitral\\:\\ 0\\.006564616669398228\ \(0\)\
\-\ remove\\:\\ 0\\.006530239035536102\ \(0\)\
\-\ as\\:\\ 0\\.0064872145841612435\ \(0\)\
\-\ ekg\\:\\ 0\\.006464186672317254\ \(0\)\
\-\ only\\:\\ 0\\.0064477080514051075\ \(0\)\
\-\ impairment\\:\\ 0\\.006401438340354065\ \(0\)\
\-\ mentioned\\:\\ 0\\.006401438340354065\ \(0\)\
\-\ tachypnea\\:\\ 0\\.006371203018422997\ \(0\)\
\-\ cyanosis\\:\\ 0\\.006284637307648906\ \(0\)\
\-\ considerations\\:\\ 0\\.006177789367447768\ \(0\)\
\-\ outpatient\\:\\ 0\\.006103230496091681\ \(0\)\
\-\ uncomplicated\\:\\ 0\\.006032854753744074\ \(0\)\
\-\ cardiovascular\\:\\ 0\\.006010246842197426\ \(0\)\
\-\ ct\\:\\ 0\\.005999014571603728\ \(0\)\
\-\ deviation\\:\\ 0\\.005988039091759031\ \(0\)\
\-\ option\\:\\ 0\\.005988039091759031\ \(0\)\
\-\ however\\:\\ 0\\.005970810679039072\ \(0\)\
\-\ borders\\:\\ 0\\.005966217582710262\ \(0\)\
\-\ s2\\:\\ 0\\.005902941731233609\ \(0\)\
\-\ nearly\\:\\ 0\\.005902941731233609\ \(0\)\
\-\ tuberous\\:\\ 0\\.005902941731233609\ \(0\)\
\-\ discussed\\:\\ 0\\.005862463861449141\ \(0\)\
\-\ remained\\:\\ 0\\.005842704316947084\ \(0\)\
\-\ infiltration\\:\\ 0\\.005842704316947084\ \(0\)\
\-\ infiltrating\\:\\ 0\\.005823251134342359\ \(0\)\
\-\ little\\:\\ 0\\.005823251134342359\ \(0\)\
\-\ slowly\\:\\ 0\\.005823251134342359\ \(0\)\
\-\ at\\:\\ 0\\.005810605534914092\ \(0\)\
\-\ continue\\:\\ 0\\.005785226856431032\ \(0\)\
\-\ pericardial\\:\\ 0\\.005766638292083301\ \(0\)\
\-\ axis\\:\\ 0\\.005712469945953805\ \(0\)\
\-\ every\\:\\ 0\\.005694921336198799\ \(0\)\
\-\ mild\\:\\ 0\\.005646809169212388\ \(0\)\
\-\ 31\\:\\ 0\\.005627082915533459\ \(0\)\
\-\ evidence\\:\\ 0\\.0056221896696784885\ \(0\)\
\-\ becomes\\:\\ 0\\.005610681307544309\ \(0\)\
\-\ born\\:\\ 0\\.005594491339117825\ \(0\)\
\-\ continues\\:\\ 0\\.005594491339117825\ \(0\)\
\-\ complicated\\:\\ 0\\.005562724955197762\ \(0\)\
\-\ s1\\:\\ 0\\.005531743007154636\ \(0\)\
\-\ nonspecific\\:\\ 0\\.005516534273738895\ \(0\)\
\-\ delivery\\:\\ 0\\.005501507685223568\ \(0\)\
\-\ atrial\\:\\ 0\\.005486658930333979\ \(0\)\
\-\ 75\\:\\ 0\\.005486658930333979\ \(0\)\
\-\ rr\\:\\ 0\\.00547198384907527\ \(0\)\
\-\ walls\\:\\ 0\\.00547198384907527\ \(0\)\
\-\ next\\:\\ 0\\.005443138782293967\ \(0\)\
\-\ except\\:\\ 0\\.005428961172188655\ \(0\)\
\-\ by\\:\\ 0\\.005355850325890369\ \(0\)\
\-\ 2nd\\:\\ 0\\.005347103553784137\ \(0\)\
\-\ need\\:\\ 0\\.005347103553784137\ \(0\)\
\-\ thus\\:\\ 0\\.005333965159973227\ \(0\)\
\-\ overall\\:\\ 0\\.005333965159973227\ \(0\)\
\-\ uncommon\\:\\ 0\\.005245658012216891\ \(0\)\
\-\ hr\\:\\ 0\\.005221528323474247\ \(0\)\
\-\ and\\:\\ 0\\.005194739186751599\ \(0\)\
\-\ larger\\:\\ 0\\.005163159420544644\ \(0\)\
\-\ vital\\:\\ 0\\.005129398500946245\ \(0\)\
\-\ unlikely\\:\\ 0\\.0051073855653742135\ \(0\)\
\-\ involve\\:\\ 0\\.005053985798223905\ \(0\)\
\-\ without\\:\\ 0\\.0050489665404219826\ \(0\)\
\-\ despite\\:\\ 0\\.004982849858855592\ \(0\)\
\-\ though\\:\\ 0\\.004973008983747655\ \(0\)\
\-\ unable\\:\\ 0\\.00495355580114293\ \(0\)\
\-\ regular\\:\\ 0\\.004943941155289017\ \(0\)\
\-\ small\\:\\ 0\\.004939963072474576\ \(0\)\
\-\ term\\:\\ 0\\.0049062028174756194\ \(0\)\
\-\ require\\:\\ 0\\.0049062028174756194\ \(0\)\
\-\ r\\:\\ 0\\.004869566487874286\ \(0\)\
\-\ well\\:\\ 0\\.004850893232041784\ \(0\)\
\-\ 22\\:\\ 0\\.004782399144317489\ \(0\)\
\-\ until\\:\\ 0\\.004708812284742197\ \(0\)\
\-\ clinically\\:\\ 0\\.004700896137699205\ \(0\)\
\-\ growth\\:\\ 0\\.004662047673955206\ \(0\)\
\-\ bp\\:\\ 0\\.004654420263570787\ \(0\)\
\-\ complaints\\:\\ 0\\.004654420263570787\ \(0\)\
\-\ do\\:\\ 0\\.004654420263570787\ \(0\)\
\-\ children\\:\\ 0\\.004631812352024139\ \(0\)\
\-\ via\\:\\ 0\\.004602288515875841\ \(0\)\
\-\ relatively\\:\\ 0\\.004587783092536975\ \(0\)\
\-\ function\\:\\ 0\\.004545246641250047\ \(0\)\
\-\ before\\:\\ 0\\.004538295348432462\ \(0\)\
\-\ compared\\:\\ 0\\.004538295348432462\ \(0\)\
\-\ \\(\\:\\ 0\\.004531754869785826\ \(0\)\
\-\ and\\/or\\:\\ 0\\.004531382354943165\ \(0\)\
\-\ limited\\:\\ 0\\.004524507241060322\ \(0\)\
\-\ distress\\:\\ 0\\.004517669593924105\ \(0\)\
\-\ \\)\\:\\ 0\\.004476397064700785\ \(0\)\
\-\ respiratory\\:\\ 0\\.004451267584571104\ \(0\)\
\-\ treatment\\:\\ 0\\.0043403185937287\ \(0\)\
\-\ aortic\\:\\ 0\\.004339939961473633\ \(0\)\
\-\ slightly\\:\\ 0\\.0043340354557805175\ \(0\)\
\-\ considered\\:\\ 0\\.004328158605953133\ \(0\)\
\-\ includes\\:\\ 0\\.004322309154126519\ \(0\)\
\-\ filling\\:\\ 0\\.004316486846025511\ \(0\)\
\-\ irregular\\:\\ 0\\.004276470078427076\ \(0\)\
\-\ currently\\:\\ 0\\.004248648425360172\ \(0\)\
\-\ also\\:\\ 0\\.004227401740703014\ \(0\)\
\-\ stenosis\\:\\ 0\\.00420007312776834\ \(0\)\
\-\ rate\\:\\ 0\\.004179073388300932\ \(0\)\
\-\ subsequent\\:\\ 0\\.00417387791444142\ \(0\)\
\-\ pleural\\:\\ 0\\.00416355106483475\ \(0\)\
\-\ rare\\:\\ 0\\.00416355106483475\ \(0\)\
\-\ \\<\\:\\ 0\\.004138099783565609\ \(0\)\
\-\ about\\:\\ 0\\.004133070898499689\ \(0\)\
\-\ effusion\\:\\ 0\\.004074245822089587\ \(0\)\
\-\ lungs\\:\\ 0\\.004059960599724311\ \(0\)\
\-\ its\\:\\ 0\\.004045836190032172\ \(0\)\
\-\ commonly\\:\\ 0\\.004045836190032172\ \(0\)\
\-\ tumors\\:\\ 0\\.004027247625684443\ \(0\)\
\-\ clear\\:\\ 0\\.003964274295039706\ \(0\)\
\-\ abnormality\\:\\ 0\\.00395553066979994\ \(0\)\
\-\ above\\:\\ 0\\.003929659544075052\ \(0\)\
\-\ sinus\\:\\ 0\\.003921153035937814\ \(0\)\
\-\ early\\:\\ 0\\.003921153035937814\ \(0\)\
\-\ peripheral\\:\\ 0\\.003879464644936157\ \(0\)\
\-\ sclerosis\\:\\ 0\\.0038510856128310474\ \(0\)\
\-\ the\\:\\ 0\\.003816165951668466\ \(0\)\
\-\ obstruction\\:\\ 0\\.00378092854277219\ \(0\)\
\-\ girl\\:\\ 0\\.003769607818054953\ \(0\)\
\-\ because\\:\\ 0\\.0037509640107729583\ \(0\)\
\-\ new\\:\\ 0\\.003736245893099822\ \(0\)\
\-\ enlarged\\:\\ 0\\.0036582447558143115\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.0036243317415258305\ \(0\)\
\-\ this\\:\\ 0\\.003617831417744541\ \(0\)\
\-\ recent\\:\\ 0\\.003604415368682305\ \(0\)\
\-\ space\\:\\ 0\\.0035464956174110847\ \(0\)\
\-\ flow\\:\\ 0\\.003543354927049581\ \(0\)\
\-\ central\\:\\ 0\\.0035277683273023325\ \(0\)\
\-\ study\\:\\ 0\\.0035277683273023325\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.003488126714481483\ \(0\)\
\-\ superior\\:\\ 0\\.0034237687541457855\ \(0\)\
\-\ often\\:\\ 0\\.0034209203871011945\ \(0\)\
\-\ further\\:\\ 0\\.0034095911440404744\ \(0\)\
\-\ between\\:\\ 0\\.003398363282590017\ \(0\)\
\-\ area\\:\\ 0\\.0033900078345473865\ \(0\)\
\-\ any\\:\\ 0\\.0033762045584344964\ \(0\)\
\-\ image\\:\\ 0\\.0033490453780396496\ \(0\)\
\-\ approximately\\:\\ 0\\.0033172118275477825\ \(0\)\
\-\ be\\:\\ 0\\.003306792279407601\ \(0\)\
\-\ clinical\\:\\ 0\\.0032990085320777967\ \(0\)\
\-\ show\\:\\ 0\\.0032912872452843483\ \(0\)\
\-\ days\\:\\ 0\\.00328616599268755\ \(0\)\
\-\ during\\:\\ 0\\.0032810655582481904\ \(0\)\
\-\ age\\:\\ 0\\.0032633755653002586\ \(0\)\
\-\ patient\\:\\ 0\\.003224310906837094\ \(0\)\
\-\ month\\:\\ 0\\.003216580352321969\ \(0\)\
\-\ lung\\:\\ 0\\.003105594881102567\ \(0\)\
\-\ edema\\:\\ 0\\.003032526335547416\ \(0\)\
\-\ all\\:\\ 0\\.003032526335547416\ \(0\)\
\-\ blood\\:\\ 0\\.00292648817127892\ \(0\)\
\-\ been\\:\\ 0\\.002916932107232109\ \(0\)\
\-\ if\\:\\ 0\\.002909339314655753\ \(0\)\
\-\ patients\\:\\ 0\\.0027748740268080624\ \(0\)\
\-\ more\\:\\ 0\\.002681526109551024\ \(0\)\
\-\ none\\:\\ 0\\.002659622969771652\ \(0\)\
\-\ in\\:\\ 0\\.0026436463622349746\ \(0\)\
\-\ of\\:\\ 0\\.002631202527432612\ \(0\)\
\-\ 1\\:\\ 0\\.002551225053901765\ \(0\)\
\-\ \\;\\:\\ 0\\.0025413063845076455\ \(0\)\
\-\ associated\\:\\ 0\\.002530065949695987\ \(0\)\
\-\ 3\\:\\ 0\\.0025106342869592718\ \(0\)\
\-\ other\\:\\ 0\\.0024713156194510017\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0024620066885576155\ \(0\)\
\-\ it\\:\\ 0\\.002410098349476809\ \(0\)\
\-\ contrast\\:\\ 0\\.0023999694941128046\ \(0\)\
\-\ exam\\:\\ 0\\.0023553750814925196\ \(0\)\
\-\ have\\:\\ 0\\.0023217541761168027\ \(0\)\
\-\ lateral\\:\\ 0\\.0023170238966430993\ \(0\)\
\-\ right\\:\\ 0\\.0022625638873536177\ \(0\)\
\-\ surgical\\:\\ 0\\.00225372869542215\ \(0\)\
\-\ after\\:\\ 0\\.0022183202040266027\ \(0\)\
\-\ lesion\\:\\ 0\\.0021838835959855137\ \(0\)\
\-\ \\.\\:\\ 0\\.0021379896269418082\ \(0\)\
\-\ within\\:\\ 0\\.0020453342639724986\ \(0\)\
\-\ for\\:\\ 0\\.001829631489693137\ \(0\)\
\-\ normal\\:\\ 0\\.0016808186381419084\ \(0\)\
\-\ there\\:\\ 0\\.0015956280507716293\ \(0\)\
\-\ not\\:\\ 0\\.001549333339701299\ \(0\)\
\-\ an\\:\\ 0\\.001482640984046085\ \(0\)\
\-\ \\:\\:\\ 0\\.0014181616260861543\ \(0\)\
\-\ was\\:\\ 0\\.0012399968911087664\ \(0\)\
\-\ with\\:\\ 0\\.0011744459331482031\ \(0\)\
\-\ old\\:\\ 0\\.001097784939601323\ \(0\)\
\-\ on\\:\\ 0\\.0009082697771209887\ \(0\)\
